Similar Papers

Paper Title
Journal
Date
Author
Chemotherapy for recurrent and metastatic cervical cancer
Xia Tao ... John J Kavanagh
Gynecologic Oncology | VOL. 110
Xia Tao, et. al.Xia Tao ... John J Kavanagh
03 Jun 2008
Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.
Veronica Agostinelli ... Sara Lardino
Cancer Management and Research | VOL. 15
Veronica Agostinelli, et. al.Veronica Agostinelli ... Sara Lardino
01 Sep 2023
Maintenance Therapy for Recurrent or Metastatic Cervical Cancer: A Multicenter, Cohort Study
C Peng ... P Xie
International Journal of Radiation Oncology*Biology*Physics | VOL. 117
C Peng, et. al.C Peng ... P Xie
29 Sep 2023
Maintenance therapy for patients with recurrent or metastatic cervical cancer: A multicentre, cohort study.
Chen Peng ... Peng Xie
Journal of Clinical Oncology | VOL. 41
Chen Peng, et. al.Chen Peng ... Peng Xie
01 Jun 2023
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Aine Clements ... Angeles Alvarez Secord
Gynecologic oncology | VOL. 193
Aine Clements, et. al.Aine Clements ... Angeles Alvarez Secord
23 Jan 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results.
David M O'Malley ... Michele Maio
Gynecologic oncology | VOL. 193
David M O'Malley, et. al.David M O'Malley ... Michele Maio
22 Jan 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.
Michael D Toboni ... Nathaniel Jones
Gynecologic oncology | VOL. 193
Michael D Toboni, et. al.Michael D Toboni ... Nathaniel Jones
20 Jan 2025
Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situ.
M Schaafsma ... N.E Van Trommel
Gynecologic oncology | VOL. 193
M Schaafsma, et. al.M Schaafsma ... N.E Van Trommel
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.